Trial Profile
Phase II Study to Evaluate Efficacy and Safety of ANTG-ASC (Autologous Cultured Adipose-derived Stem Cells) on the Complex Fistula Patients
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 25 Nov 2016
Price :
$35
*
At a glance
- Drugs Adipose stem cell therapy Anterogen (Primary)
- Indications Rectal fistula
- Focus Therapeutic Use
- Sponsors Anterogen
- 21 Nov 2016 Status changed from recruiting to discontinued as there was Difficulty recruiting subjects.
- 04 Nov 2014 New trial record